Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00157963
Status:
COMPLETED
Last Update Posted:
2022-02-15
First Post:
2005-09-07
Brief Title:
Hydrochlorothiazide Losartan Potassium vs Amlodipine Comparative Study 0954A-314
Sponsor:
Organon and Co
Organization:
Organon and Co
Study Overview
Official Title:
A 12 Week Open Randomized Parallel Multicenter Study of Efficacy Tolerability Safety of Hydrochlorothiazide Losartan Potassium Versus Amlodipine in Essential Hypertensive Patients
Status:
COMPLETED
Status Verified Date:
2022-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
An efficacy and safety study of hydrochlorothiazide losartan potassium compared to amlodipine at week 12 in Korean patients with essential hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_067 | None | None | None |